Clinical Trial

Transcranial Electrical Stimulation for Treating Chronic Pain in Inflammatory Demyelinating Diseases

Recruiting
View on ClinicalTrials.gov →
Summary
Non-invasive neurostimulation can effectively improve patients' symptoms and has shown good therapeutic efficacy in alleviating the symptoms of IIDDs (Inflammatory Immune-mediated Demyelinating Diseases). However, some patients have not achieved the desired results, which may be due to individual differences in neural responsiveness . Therefore, this study aims to assess the therapeutic effect of transcranial electrical stimulation on improving symptoms such as painful spasm in IIDDs patients, by considering both the overall characteristics of IIDDs disease symptoms and individual differences in patients. The study will explore the imaging characteristics, electrophysiological features of the disease symptoms, and their relationship with clinical manifestations, while analyzing the key factors that influence treatment efficacy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-16; most recent amendment 2025-06-26.
Trial Details
NCT Number NCT06942611
Lead Sponsor Xuanwu Hospital, Beijing
Conditions Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
Enrollment 80 participants
Start Date 2025-05-03
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-01